November 12, 2020

Medicare to cover monoclonal antibody COVID-19 treatments

By: Judy Mathias

Editor's Note

The Centers for Medicare and Medicaid Services (CMS) on November 10 announced that Medicare will cover out-of-pocket costs for monoclonal antibody drugs for COVID-19 during the public health emergency.

The agency’s coverage includes Eli Lilly’s bamlanivimab, which recently received an emergency use authorization from the Food and Drug Administration.

Sponsored Message

Medicare won’t pay for monoclonal antibody products that providers receive for free, but it will pay for the infusion.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat